Author Question: On which of the following pharmacological dimensions does cannabis (delta-9-THC) differ ... (Read 8 times)

scienceeasy

  • Hero Member
  • *****
  • Posts: 565
On which of the following pharmacological dimensions does cannabis (delta-9-THC) differ significantly from LSD, psilocybin and mescaline?
 
  a. the degree to which they induce profound and intense perceptual distortions and hallucinatory experiences
  b. their effects on wakefulness
  c. the rate at which tolerance develops to their subjective effects
  d. all of these

Question 2

The major psychoactive compound in marijuana, delta-9-THC, has actions mediated by CB1 receptors. An endogenous ligand for this class of receptors is called
 
  a. dopamine
  b. serotonin
  c. acetylcholine
  d. anandamide



xiaomengxian

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

d

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

The most common treatment options for addiction include psychotherapy, support groups, and individual counseling.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

For a complete list of videos, visit our video library